Clinical Trials Browser

Nasopharyngeal Carcinoma, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06136962 2023-11-18

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life

Unknown

500 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05202626 2023-10-17

Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images

Unknown

100 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05519956 2022-09-19

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Phase 3 Unknown

398 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04955886 2021-07-09

Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

14 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04745741 2021-04-29

Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC

Unknown

200 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03648697 2020-08-11

EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC

Phase 2 Unknown

20 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04421469 2020-06-09

Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC

Phase 2 Unknown

39 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04319471 2020-03-24

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

70 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04220528 2020-01-07

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

Phase 2 Unknown

129 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03666221 2018-09-11

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Phase 2 Unknown

67 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT00577057 2013-08-22

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Phase NA Unknown

798 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT01086488 2011-07-08

FOSCAN

Phase 2 Unknown

66 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT00563927 2010-07-07

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)

Phase NA Unknown

340 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Carcinoma, Squamous Cell, Nasopharyngeal Neoplasms

Clinical Trials

A-TRAIN

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life

Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images

Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines

Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma

Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC

EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC

Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

FOSCAN

Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)